Symbol="NEXI"
AssetType="Common Stock"
Name="Neximmune Inc"
Description="NexImmune, Inc., a clinical-stage biotechnology company, is dedicated to developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. The company is headquartered in Gaithersburg, Maryland."
CIK="1538210"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="9119 GAITHER ROAD, GAITHERSBURG, MD, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="7820900"
EBITDA="-56823176"
PERatio="None"
PEGRatio="None"
BookValue="0.904"
DividendPerShare="0"
DividendYield="0"
EPS="-2.11"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.664"
ReturnOnEquityTTM="-1.214"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.11"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="2"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.19"
EVToRevenue="-"
EVToEBITDA="0.592"
Beta="2.19"
num_52WeekHigh="1.63"
num_52WeekLow="0.195"
num_50DayMovingAverage="0.316"
num_200DayMovingAverage="0.417"
SharesOutstanding="26078500"
DividendDate="None"
ExDividendDate="None"
symbol="NEXI"
open="0.31"
high="0.31"
low="0.29"
price="0.30"
volume="92855.00"
latest_trading_day="2023-07-18"
previous_close="0.30"
change="0.00"
change_percent="0.6376%"
aroon_positive_momentum_days="78"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="78"
Volume_recent_avg="256040"
Change_recent_avg="-0.01"
Delta_recent_avg="0.05"
Variance_recent_avg="0.02"
Change_ratio_recent_avg="-1.98"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="78"
Aroon_momentum_negative="22"
image_negative_thumbnail_id_1="513"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0092.jpeg"
image_negative_thumbnail_id_2="489"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0116.jpeg"
image_neutral_thumbnail_id_1="546"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0053.jpeg"
image_neutral_thumbnail_id_2="580"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0019.jpeg"
image_positive_thumbnail_id_1="1013"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0175.jpeg"
image_positive_thumbnail_id_2="1016"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0178.jpeg"
image_professor_thumbnail_id_1="1204"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
image_professor_thumbnail_id_2="1196"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
